News from allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 24, 2019, 07:30 ET Allergan Receives FDA Clearance For CoolTone™ Device

Allergan plc (NYSE: AGN) today announced CoolTone device received FDA clearance for improvement of abdominal tone, strengthening of the abdominal...


Jun 21, 2019, 07:30 ET FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity

Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental biologics application...


May 28, 2019, 07:30 ET Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression

Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New...


May 24, 2019, 16:05 ET Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35th Annual...


May 23, 2019, 07:30 ET Allergan to Present at the Jefferies 2019 Healthcare Conference

Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019...


May 17, 2019, 07:30 ET Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis

Allergan plc (NYSE: AGN) today announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational,...


May 16, 2019, 07:30 ET Allergan to Present at the Bernstein Strategic Decisions Conference

Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35th Annual...


May 15, 2019, 07:30 ET Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will showcase data during the upcoming American Psychiatric...


May 09, 2019, 07:30 ET Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America...


May 07, 2019, 07:00 ET Allergan Reports First Quarter 2019 Financial Results

Allergan plc (NYSE: AGN) today reported its first quarter 2019 financial results including GAAP net revenues of $3.60 billion, a 2.0 percent decrease ...


May 03, 2019, 07:45 ET Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share

Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter...


May 03, 2019, 07:30 ET Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a heritage of more than 70 years in eye care, will present new data for its...


May 02, 2019, 07:30 ET Allergan Continues to Display Leadership in Neurosciences with 29 Presentations at 2019 American Academy of Neurology Annual Meeting

Allergan plc (NYSE: AGN) announced today that the company will share 29 presentations at the 71st Annual American Academy of Neurology (AAN) Meeting, ...


May 01, 2019, 06:30 ET Allergan Announces Results from the 2019 Annual General Meeting of Shareholders

Allergan plc (NYSE: AGN) today announced the voting results, representing 85.9 percent of shares eligible to be voted, from its Annual General...


Apr 25, 2019, 07:30 ET Allergan to Showcase Continued Eye Care Innovation with New Data at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, will present new data at the Annual ...


Apr 15, 2019, 11:00 ET New Study Showcases Economic and Community Impact of Allergan's Operations in Ohio

A new study by the University of Cincinnati Economics Center finds that the Ohio operations of biopharmaceutical company Allergan have a significant...


Apr 15, 2019, 07:00 ET Leading Proxy Advisory Firms ISS and Glass Lewis Support ALL of Allergan Board's Voting Recommendations

Allergan plc (NYSE: AGN) today announced that both leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and...


Apr 10, 2019, 08:00 ET Allergan Earns 2019 ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Sixth Consecutive Year

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has received the 2019 ENERGY STAR® Partner of the Year...


Apr 09, 2019, 07:30 ET Allergan to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast

Allergan plc (NYSE: AGN) today announced it will release first quarter 2019 financial results on Tuesday, May 7, 2019, prior to the open of U.S....


Apr 08, 2019, 07:30 ET Allergan 360° Aesthetics Report™ Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World

Allergan plc (NYSE: AGN) today released the results of their first-of-its-kind worldwide medical aesthetics study, titled the Allergan 360°...


Apr 02, 2019, 07:00 ET Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company...


Mar 26, 2019, 09:00 ET Allergan Acquires Envy Medical, Inc., Adding Skin Resurfacing Dermalinfusion System to Best-in-Class Medical Aesthetics Portfolio

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has completed the acquisition of Envy Medical, Inc., a...


Mar 20, 2019, 10:00 ET CoolSculpting® and Sonja Morgan Partner to Talk Bikini Denial

Television personality on Bravo's "The Real Housewives of New York City", philanthropist, fashion lifestyle entrepreneur and mom, Sonja Morgan,...


Mar 18, 2019, 07:30 ET Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients

Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug...


Mar 14, 2019, 07:30 ET Allergan to Present New Data - "Extended Duration of Intraocular Pressure (IOP) Control with Intracameral Bimatoprost Sustained-Release (SR) Implant" -- Highlighting Clinical Advances at the American Glaucoma Society Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, will present new data including a ...